ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 345 filers reported holding ENCOMPASS HEALTH CORP in Q3 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,044 | -10.7% | 90,000 | -10.0% | 3.05% | +92.9% |
Q2 2023 | $6,769 | +127.5% | 99,976 | +81.8% | 1.58% | +23.8% |
Q1 2023 | $2,976 | -41.5% | 55,000 | -35.3% | 1.28% | -46.5% |
Q4 2022 | $5,084 | -99.9% | 85,000 | 0.0% | 2.39% | +11.9% |
Q3 2022 | $3,845,000 | +5.5% | 85,000 | +30.8% | 2.14% | +3.2% |
Q2 2022 | $3,643,000 | -37.8% | 65,000 | -21.1% | 2.07% | -14.4% |
Q1 2022 | $5,859,000 | +199.2% | 82,392 | +174.6% | 2.42% | +188.3% |
Q4 2021 | $1,958,000 | -73.9% | 30,000 | -70.0% | 0.84% | -53.2% |
Q3 2021 | $7,504,000 | +37.4% | 100,000 | +42.9% | 1.79% | +68.0% |
Q2 2021 | $5,462,000 | -25.9% | 70,000 | -22.2% | 1.07% | -60.3% |
Q1 2021 | $7,371,000 | +98.1% | 90,000 | +100.0% | 2.69% | +77.2% |
Q4 2020 | $3,721,000 | -11.9% | 45,000 | -30.8% | 1.52% | -16.5% |
Q3 2020 | $4,224,000 | -45.4% | 65,000 | +100.0% | 1.82% | -40.4% |
Q1 2020 | $7,733,000 | – | 32,500 | – | 3.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 400,000 | $25,612,000 | 9.91% |
REINHART PARTNERS, LLC. | 687,133 | $43,997,000 | 4.26% |
RK Capital | 147,290 | $9,431,000 | 4.24% |
HealthCor Management, L.P. | 1,525,809 | $97,698,000 | 4.18% |
Integral Health Asset Management, LLC | 115,000 | $7,363,000 | 3.24% |
Sivik Global Healthcare LLC | 32,500 | $7,733,000 | 3.05% |
Copeland Capital Management, LLC | 635,514 | $40,692,000 | 2.48% |
Rock Springs Capital Management LP | 815,000 | $52,184,000 | 2.16% |
Endurant Capital Management LP | 55,614 | $3,561,000 | 1.61% |
Advantage Alpha Capital Partners LP | 70,005 | $4,482,000 | 1.60% |